251 related articles for article (PubMed ID: 15072826)
1. Photoactivation of hypericin down-regulates glutathione S-transferase activity in nasopharyngeal cancer cells.
Du HY; Olivo M; Tan BK; Bay BH
Cancer Lett; 2004 Apr; 207(2):175-81. PubMed ID: 15072826
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
Du HY; Bay BH; Olivo M
Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
[TBL] [Abstract][Full Text] [Related]
3. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
Du HY; Olivo M; Tan BK; Bay BH
Int J Oncol; 2003 Nov; 23(5):1401-5. PubMed ID: 14532982
[TBL] [Abstract][Full Text] [Related]
4. Hypericin photoactivation triggers down-regulation of matrix metalloproteinase-9 expression in well-differentiated human nasopharyngeal cancer cells.
Du HY; Olivo M; Mahendran R; Huang Q; Shen HM; Ong CN; Bay BH
Cell Mol Life Sci; 2007 Apr; 64(7-8):979-88. PubMed ID: 17385073
[TBL] [Abstract][Full Text] [Related]
5. Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin.
Du HY; Li Y; Olivo M; Yip GW; Bay BH
Oncol Rep; 2006 Dec; 16(6):1397-402. PubMed ID: 17089067
[TBL] [Abstract][Full Text] [Related]
6. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Matrix metalloproteinase-1 in nasopharyngeal cancer cells by photoactivation of hypericin.
Du H; Olivo M; Mahendran R; Bay BH
Int J Oncol; 2004 Mar; 24(3):657-62. PubMed ID: 14767550
[TBL] [Abstract][Full Text] [Related]
8. Expression of Y-Box binding protein-1 following hypericin-mediated photodynamic therapy in well-differentiated nasopharyngeal cancer in vivo.
Du HY; Olivo M; Chen YJ; Yip G; Tan PH; Matsumoto K; Tsujimoto M; Bay BH
Int J Mol Med; 2005 Nov; 16(5):865-8. PubMed ID: 16211256
[TBL] [Abstract][Full Text] [Related]
9. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer.
Du H; Bay BH; Mahendran R; Olivo M
Cancer Lett; 2006 Apr; 235(2):202-8. PubMed ID: 15935550
[TBL] [Abstract][Full Text] [Related]
10. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
[TBL] [Abstract][Full Text] [Related]
11. Endogenous expression of interleukin-8 and interleukin-10 in nasopharyngeal carcinoma cells and the effect of photodynamic therapy.
Du H; Bay BH; Mahendran R; Olivo M
Int J Mol Med; 2002 Jul; 10(1):73-6. PubMed ID: 12060853
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells.
Wang X; Guo Y; Yang S; Wang C; Fu X; Wang J; Mao Y; Zhang J; Li Y
J Pharmacol Exp Ther; 2010 Sep; 334(3):847-53. PubMed ID: 20551295
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hexamethylhypericin and tetrabromohypericin to hypericin for their in vivo efficacy as PDT tools.
Delaey E; Zupko I; Chen B; Derycke A; van Laar F; De Vos D; De Witte P
Int J Oncol; 2003 Aug; 23(2):519-24. PubMed ID: 12851704
[TBL] [Abstract][Full Text] [Related]
15. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
Ali SM; Olivo M
Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096
[TBL] [Abstract][Full Text] [Related]
16. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
[TBL] [Abstract][Full Text] [Related]
17. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
[TBL] [Abstract][Full Text] [Related]
18. The multifaceted photocytotoxic profile of hypericin.
Theodossiou TA; Hothersall JS; De Witte PA; Pantos A; Agostinis P
Mol Pharm; 2009; 6(6):1775-89. PubMed ID: 19739671
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
Chen B; Zupkó I; de Witte PA
Int J Oncol; 2001 Apr; 18(4):737-42. PubMed ID: 11251168
[TBL] [Abstract][Full Text] [Related]
20. Antitumour activity of photosensitized hypericin on A431 cell xenografts.
Vandenbogaerde AL; Geboes KR; Cuveele JF; Agostinis PM; Merlevede WJ; De Witte PA
Anticancer Res; 1996; 16(4A):1619-25. PubMed ID: 8712679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
